for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

Daily Digit: Novartis raises outlook

Posted

Oct. 22 - Swiss drug maker Novartis raises its full-year outlook for a second consecutive quarter, due to the ongoing absence of generic competition to its best-selling blood pressure pill, Diovan. Hayley Platt reports.

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up